In line with the ESC mission, newly presented content is made available to all for a limited time (4 months for ESC Congress, 3 months for other events). ESC Professional Members, Association Members (Ivory & above) benefit from year-round access to all the resources from their respective Association, and to all content from previous years. Fellows of the ESC (FESC), and Professionals in training or under 40 years old, who subscribed to a Young Combined Membership package benefit from access to all ESC 365 content from all events, all editions, all year long. Find out more about ESC Memberships here.
Prognostic importance of serum chloride concentration in patients hospitalized due to worsening heart failure
Authors : A Urbinati (Ancona,IT), P Pellicori (Glasgow,GB), J Cuthbert (Cottingham,GB), D Pan (Cottingham,GB), S Kazmi (Cottingham,GB), F Guerra (Ancona,IT), A Capucci (Ancona,IT), AL Clark (Cottingham,GB), JG Cleland (Glasgow,GB)
A Urbinati1
,
P Pellicori2
,
J Cuthbert3
,
D Pan3
,
S Kazmi3
,
F Guerra1
,
A Capucci1
,
AL Clark3
,
JG Cleland2
,
1Marche Polytechnic University of Ancona - Ancona - Italy
,
2University of Glasgow - Glasgow - United Kingdom
,
3Castle Hill Hospital - Hull - United Kingdom
,
Background: Blood electrolyte disorders are common in patients hospitalized for heart failure: serum chloride is usually measured but rarely considered.
Methods and results: Between October 2012 and November 2016, patients hospitalized with worsening heart failure enrolled in the OPERA-HF, a single-centre, prospective, observational study had serum chloride measured at admission and discharge. 1145 patients (mean age 75±12 years, median NTproBNP 4999 (IQR: 2331-10971) ng/l, of whom 62% had HFrEF on echocardiography, were enrolled. Hypochloraemia (serum chloride < 96 mmol/l) was present in 161 patients (14%) at admission and in 390 patients (34%) at discharge. Compared to patients in the highest quintile (median chloride 107 mmol/l; range 105-117 mmol/l), those in the lowest quintile of serum chloride at admission (median 94 mmol/l, range 76-97 mmol/l) were more likely to die (hazard ratio [HR]: 1.88; 95% confidence interval [CI]: 1.43-2.47, p<0.001). Increasing chloride, but not sodium or potassium, levels at admission were independently associated with lower all-cause mortality (HR 0.94; 95% CI 0.89 to 0.99; p=0.035). Compared to those who had normal chloride levels at admission and discharge, those who developed hypochloraemia during admission (HR:1.58; 95% CI 1.29-1.93, p<0.001), or those who remained hypochloraemic (HR: 2.07; 95% CI 1.61-2.66, p<0.001 ) had a higher mortality. Patients in whom hypochloraemia was corrected during hospitalisation had the same survival as those who were never hypochloraemic (HR: 1.08; 95% CI 0.65-1.79, p=0.761).
Conclusion: Hypochloraemia is a common electrolyte disorder in patients admitted with worsening heart failure and is a powerful predictor of increasing mortality.
In line with the ESC mission, newly presented content is made available to all for a limited time (4 months for ESC Congress, 3 months for other events). ESC Professional Members, Association Members (Ivory & above) benefit from year-round access to all the resources from their respective Association, and to all content from previous years. Fellows of the ESC (FESC), and Professionals in training or under 40 years old, who subscribed to a Young Combined Membership package benefit from access to all ESC 365 content from all events, all editions, all year long. Find out more about ESC Memberships here.